These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33554088)

  • 1. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries.
    Jo Y; Gomes I; Flack J; Salazar-Austin N; Churchyard G; Chaisson RE; Dowdy DW
    EClinicalMedicine; 2021 Jan; 31():100707. PubMed ID: 33554088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis.
    Ryckman T; Weiser J; Gombe M; Turner K; Soni P; Tarlton D; Mazhidova N; Churchyard G; Chaisson RE; Dowdy DW
    Lancet Glob Health; 2023 Aug; 11(8):e1205-e1216. PubMed ID: 37474228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV.
    Shin H; Jo Y; Chaisson RE; Turner K; Churchyard G; Dowdy DW
    J Int AIDS Soc; 2020 Oct; 23(10):e25629. PubMed ID: 33107219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
    PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
    Mafirakureva N; Mukherjee S; de Souza M; Kelly-Cirino C; Songane MJP; Cohn J; Lemaire JF; Casenghi M; Dodd PJ
    PLoS Med; 2023 Sep; 20(9):e1004285. PubMed ID: 37672524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a modeling study.
    Sinha P; Dauphinais M; Carwile ME; Horsburgh CR; Menzies NA
    medRxiv; 2024 Jan; ():. PubMed ID: 38260435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of community-based household tuberculosis contact management for children in Cameroon and Uganda: a modelling analysis of a cluster-randomised trial.
    Mafirakureva N; Tchounga BK; Mukherjee S; Youngui BT; Ssekyanzi B; Simo L; Okello RF; Turyahabwe S; Kuate Kuate A; Cohn J; Vasiliu A; Casenghi M; Atwine D; Bonnet M; Dodd PJ
    Lancet Glob Health; 2023 Dec; 11(12):e1922-e1930. PubMed ID: 37918416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.
    Currie CS; Floyd K; Williams BG; Dye C
    BMC Public Health; 2005 Dec; 5():130. PubMed ID: 16343345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
    Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
    BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Tuberculosis Screening via a Mobile Health App in Myanmar: Incremental Cost-Effectiveness Evaluation.
    Htet KKK; Phyu AN; Zayar NN; Chongsuvivatwong V
    JMIR Form Res; 2023 Nov; 7():e51998. PubMed ID: 37948119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
    Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
    PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling up antivenom for snakebite envenoming in the Brazilian Amazon: a cost-effectiveness analysis.
    Zimmerman A; Monteiro W; Nickenig Vissoci JR; Smith ER; Rocha T; Sachett J; Wen FH; Staton C; Gerardo CJ; Ogbuoji O
    Lancet Reg Health Am; 2024 Jan; 29():100651. PubMed ID: 38124996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.
    Dodd PJ; Mafirakureva N; Seddon JA; McQuaid CF
    Lancet Glob Health; 2022 Jul; 10(7):e1034-e1044. PubMed ID: 35597248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings.
    Johnson KT; Churchyard GJ; Sohn H; Dowdy DW
    Clin Infect Dis; 2018 Sep; 67(7):1072-1078. PubMed ID: 29617965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of household contact investigation for detection of tuberculosis in Pakistan.
    Hussain H; Malik A; Ahmed JF; Siddiqui S; Amanullah F; Creswell J; Tylleskär T; Robberstad B
    BMJ Open; 2021 Oct; 11(10):e049658. PubMed ID: 34686551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial.
    Vasiliu A; Eymard-Duvernay S; Tchounga B; Atwine D; de Carvalho E; Ouedraogo S; Kakinda M; Tchendjou P; Turyahabwe S; Kuate AK; Tiendrebeogo G; Dodd PJ; Graham SM; Cohn J; Casenghi M; Bonnet M
    Trials; 2021 Mar; 22(1):180. PubMed ID: 33653385
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.